{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:53:40Z","timestamp":1782773620456,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangzhou Health Science and Technology Project","award":["20231A041009"],"award-info":[{"award-number":["20231A041009"]}]},{"name":"Guangzhou Health Science and Technology Project","award":["20241A010110"],"award-info":[{"award-number":["20241A010110"]}]},{"name":"the Panyu District Science and Technology Plan Key Projects in Medicine and Health","award":["2022-Z04-106"],"award-info":[{"award-number":["2022-Z04-106"]}]},{"name":"the Panyu District Science and Technology Plan Key Projects in Medicine and Health","award":["2022-Z04-114"],"award-info":[{"award-number":["2022-Z04-114"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-19693-1","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T14:44:00Z","timestamp":1760453040000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Netrin-1 as a molecular mediator linking APOE \u03b54 to alzheimer\u2019s disease pathogenesis"],"prefix":"10.1038","volume":"15","author":[{"given":"Bingjie","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenfa","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijie","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"19693_CR1","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1002\/alz.13809","volume":"20","author":"Alzheimer\u2019s Disease Facts and Figures","year":"2024","unstructured":"Alzheimer\u2019s Disease Facts and Figures. Alzheimer\u2019s Dement. 20, 3708\u20133821 (2024).","journal-title":"Alzheimer\u2019s Dement."},{"key":"19693_CR2","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens, P. et al. Alzheimer\u2019s disease. Lancet 397, 1577\u20131590 (2021).","journal-title":"Lancet"},{"key":"19693_CR3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3233\/JAD-2010-1221","volume":"19","author":"MP Murphy","year":"2010","unstructured":"Murphy, M. P. & LeVine, H. R. Alzheimer\u2019s disease and the Amyloid-Beta peptide. J. Alzheimers Dis. 19, 311\u2013323 (2010).","journal-title":"J. Alzheimers Dis."},{"key":"19693_CR4","doi-asserted-by":"crossref","unstructured":"Rather, M. A. et al. Inflammation and Alzheimer\u2019s Disease: Mechanisms and Therapeutic Implications by Natural Products. Mediat. Inflamm. 9982954 (2021). (2021).","DOI":"10.1155\/2021\/9982954"},{"key":"19693_CR5","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"CC Liu","year":"2013","unstructured":"Liu, C. C., Liu, C. C., Kanekiyo, T., Xu, H. & Bu, G. Apolipoprotein E and alzheimer disease: risk, mechanisms and therapy. Nat. Rev. Neurol. 9, 106\u2013118 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"19693_CR6","doi-asserted-by":"publisher","first-page":"630502","DOI":"10.3389\/fnins.2021.630502","volume":"15","author":"MA Husain","year":"2021","unstructured":"Husain, M. A., Laurent, B. & Plourde, M. Apoe and alzheimer\u2019s disease: from lipid transport to physiopathology and therapeutics. Front. Neurosci. 15, 630502 (2021).","journal-title":"Front. Neurosci."},{"key":"19693_CR7","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer, L. A. et al. Effects of age, sex, and ethnicity on the association between Apolipoprotein E genotype and alzheimer disease. A meta-Analysis. Apoe and alzheimer disease.Meta analysis consortium. Jama-J Am. Med. Assoc. 278, 1349\u20131356 (1997).","journal-title":"Jama-J Am. Med. Assoc."},{"key":"19693_CR8","doi-asserted-by":"publisher","first-page":"6027","DOI":"10.1074\/jbc.R800009200","volume":"284","author":"N Zhong","year":"2009","unstructured":"Zhong, N. & Weisgraber, K. H. Understanding the association of Apolipoprotein E4 with alzheimer disease: clues from its structure. J. Biol. Chem. 284, 6027\u20136031 (2009).","journal-title":"J. Biol. Chem."},{"key":"19693_CR9","doi-asserted-by":"crossref","unstructured":"Dias, D., Portugal, C. C., Relvas, J. & Socodato, R. From Genetics to Neuroinflammation: The Impact of Apoe4 On Microglial Function in Alzheimer\u2019s Disease. Cells 14, (2025).","DOI":"10.3390\/cells14040243"},{"key":"19693_CR10","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s00109-016-1427-y","volume":"94","author":"RW Mahley","year":"2016","unstructured":"Mahley, R. W. & Apolipoprotein, E. From cardiovascular disease to neurodegenerative disorders. J. Mol. Med. 94, 739\u2013746 (2016).","journal-title":"J. Mol. Med."},{"key":"19693_CR11","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.neuron.2024.01.008","volume":"112","author":"A Chemparathy","year":"2024","unstructured":"Chemparathy, A. et al. Apoe Loss-of-Function variants: compatible with longevity and associated with resistance to alzheimer\u2019s disease pathology. Neuron 112, 1110\u20131116 (2024).","journal-title":"Neuron"},{"key":"19693_CR12","doi-asserted-by":"publisher","first-page":"960","DOI":"10.4103\/NRR.NRR-D-23-01573","volume":"20","author":"K Zhu","year":"2025","unstructured":"Zhu, K., Wang, H., Ye, K., Chen, G. & Zhang, Z. Netrin-1 signaling pathway mechanisms in neurodegenerative diseases. Neural Regen Res. 20, 960\u2013972 (2025).","journal-title":"Neural Regen Res."},{"key":"19693_CR13","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/cdd.2008.191","volume":"16","author":"FC Lourenco","year":"2009","unstructured":"Lourenco, F. C. et al. Netrin-1 interacts with amyloid precursor protein and regulates amyloid-Beta production. Cell. Death Differ. 16, 655\u2013663 (2009).","journal-title":"Cell. Death Differ."},{"key":"19693_CR14","doi-asserted-by":"publisher","first-page":"762649","DOI":"10.3389\/fnagi.2021.762649","volume":"13","author":"T Ju","year":"2021","unstructured":"Ju, T. et al. Decreased Netrin-1 in mild cognitive impairment and alzheimer\u2019s disease patients. Front. Aging Neurosci. 13, 762649 (2021).","journal-title":"Front. Aging Neurosci."},{"key":"19693_CR15","doi-asserted-by":"publisher","first-page":"100149","DOI":"10.1016\/j.crphar.2022.100149","volume":"4","author":"V Rani","year":"2023","unstructured":"Rani, V., Verma, R., Kumar, K. & Chawla, R. Role of Pro-Inflammatory cytokines in alzheimer\u2019s disease and neuroprotective effects of pegylated Self-Assembled nanoscaffolds. Curr. Res. Pharmacol. Drug Discov. 4, 100149 (2023).","journal-title":"Curr. Res. Pharmacol. Drug Discov"},{"key":"19693_CR16","doi-asserted-by":"crossref","unstructured":"Twarowski, B. & Herbet, M. Inflammatory Processes in Alzheimer\u2019s Disease-Pathomechanism, Diagnosis and Treatment: A Review. Int J. Mol. Sci 24, (2023).","DOI":"10.3390\/ijms24076518"},{"key":"19693_CR17","doi-asserted-by":"publisher","first-page":"4499","DOI":"10.1002\/alz.13867","volume":"20","author":"S Oveisgharan","year":"2024","unstructured":"Oveisgharan, S. et al. Proteins linking Apoe Varepsilon4 with alzheimer\u2019s disease. Alzheimers Dement. 20, 4499\u20134511 (2024).","journal-title":"Alzheimers Dement."},{"key":"19693_CR18","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41398-021-01349-z","volume":"11","author":"ESN Lyra","year":"2021","unstructured":"Lyra, E. S. N. et al. Pro-Inflammatory Interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in alzheimer\u2019s disease. Transl Psychiatr. 11, 251 (2021).","journal-title":"Transl Psychiatr"},{"key":"19693_CR19","doi-asserted-by":"publisher","first-page":"e105537","DOI":"10.15252\/embj.2020105537","volume":"40","author":"M Jasmin","year":"2021","unstructured":"Jasmin, M. et al. Netrin-1 and its receptor Dcc modulate survival and death of dopamine neurons and parkinson\u2019s disease features. Embo J. 40, e105537 (2021).","journal-title":"Embo J."},{"key":"19693_CR20","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.celrep.2018.09.028","volume":"25","author":"SD Glasgow","year":"2018","unstructured":"Glasgow, S. D. et al. Activity-Dependent Netrin-1 secretion drives synaptic insertion of Glua1-Containing Ampa receptors in the hippocampus. Cell. Rep. 25, 168\u2013182 (2018).","journal-title":"Cell. Rep."},{"key":"19693_CR21","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1515\/rns.2011.035","volume":"22","author":"C Marchetti","year":"2011","unstructured":"Marchetti, C. & Marie, H. Hippocampal synaptic plasticity in alzheimer\u2019s disease: what have we learned so Far from Transgenic models?? Rev. Neurosci. 22, 373\u2013402 (2011).","journal-title":"Rev. Neurosci."},{"key":"19693_CR22","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1113\/JP278704","volume":"599","author":"SD Glasgow","year":"2021","unstructured":"Glasgow, S. D., Ruthazer, E. S. & Kennedy, T. E. Guiding synaptic plasticity: novel roles for Netrin-1 in synaptic plasticity and memory formation in the adult brain. J. Physiol. -London. 599, 493\u2013505 (2021).","journal-title":"J. Physiol. -London"},{"issue":"Suppl 1","key":"19693_CR23","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1471-4159.2011.07506.x","volume":"120","author":"T Ma","year":"2012","unstructured":"Ma, T. & Klann, E. Amyloid beta: linking synaptic plasticity failure to memory disruption in alzheimer\u2019s disease. J. Neurochem. 120 (Suppl 1), 140\u2013148 (2012).","journal-title":"J. Neurochem"},{"key":"19693_CR24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.brainresbull.2017.03.015","volume":"131","author":"M Shabani","year":"2017","unstructured":"Shabani, M. et al. Netrin-1 improves the Amyloid-Beta-Mediated suppression of memory and synaptic plasticity. Brain Res. Bull. 131, 107\u2013116 (2017).","journal-title":"Brain Res. Bull."},{"key":"19693_CR25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3233\/JAD-151046","volume":"52","author":"PR Spilman","year":"2016","unstructured":"Spilman, P. R. et al. Netrin-1 interrupts Amyloid-Beta amplification, increases Sabetappalpha in vitro and in vivo, and improves cognition in a mouse model of alzheimer\u2019s disease. J. Alzheimers Dis. 52, 223\u2013242 (2016).","journal-title":"J. Alzheimers Dis."},{"key":"19693_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13287-017-0494-5","volume":"8","author":"CP Prieto","year":"2017","unstructured":"Prieto, C. P. et al. Netrin-1 acts as a Non-Canonical angiogenic factor produced by human wharton\u2019s jelly mesenchymal stem cells (Wj-Msc). Stem Cell. Res. Ther. 8, 43 (2017).","journal-title":"Stem Cell. Res. Ther."},{"key":"19693_CR27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1165\/rcmb.2019-0209OC","volume":"63","author":"O Kalchiem-Dekel","year":"2020","unstructured":"Kalchiem-Dekel, O. et al. Apolipoprotein E signals via Tlr4 to induce Cxcl5 secretion by asthmatic airway epithelial cells. Am. J. Respir Cell. Mol. Biol. 63, 185\u2013197 (2020).","journal-title":"Am. J. Respir Cell. Mol. Biol."},{"key":"19693_CR28","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/jnc.13072","volume":"133","author":"LM Tai","year":"2015","unstructured":"Tai, L. M. et al. Apoe-Modulated Abeta-Induced neuroinflammation in alzheimer\u2019s disease: current landscape, novel data, and future perspective. J. Neurochem. 133, 465\u2013488 (2015).","journal-title":"J. Neurochem"},{"key":"19693_CR29","first-page":"173","volume":"39","author":"MJ Rudolph","year":"1984","unstructured":"Rudolph, M. J. & Cleaton-Jones, P. E. Black and white pregnant women in johannesburg, South Africa. J. Dent. Assoc. S Afr. 39, 173\u2013176 (1984).","journal-title":"J. Dent. Assoc. S Afr."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19693-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19693-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19693-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T14:44:02Z","timestamp":1760453042000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19693-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["19693"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-19693-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"15 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The ethics review was approved by the Medical Ethics Committee of Guangzhou Panyu Health Management Center (Guangzhou Panyu Rehabilitation Hospital) (2022-13), and informed consent was obtained from all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}],"article-number":"35822"}}